Midgard Science

CN Bio

Cambridge cn-bio.com

From their website, Nov 2026

Work here? Claim this listing

About

CN Bio develops organ-on-a-chip and microphysiological systems for human-relevant drug discovery, safety toxicology, and ADME studies. It provides in vitro contract research services and products to biopharma and research teams working on disease modeling, translational pharmacology, and preclinical decision-making. The company is based in Cambridge, UK, and serves customers through global distributors and direct contact in the UK and US.

Services

  • In vitro services

    Standard and bespoke organ-on-a-chip contract research studies designed around customer goals to generate actionable data.

    Assays & in vitro testing

  • MASH in vitro services

    Human-relevant liver-on-a-chip studies for evaluating anti-MASH therapeutics, fibrosis, steatosis, inflammation, and cell health biomarkers.

    Assays & in vitro testing

  • Drug-induced liver injury (DILI) in vitro services

    Hepatotoxicity studies using Liver-on-a-chip models to assess human DILI risk, cross-species differences, and multiple liver health endpoints.

    Assays & in vitro testing

  • ADME services

    In vitro studies to investigate drug metabolism, metabolite identification, permeability, and bioavailability using organ-on-a-chip models.

    Assays & in vitro testing

  • PhysioMimix Core

    Microphysiological system hardware used to recreate complex human biology with organ-on-a-chip workflows.

  • Consumables

    Multi-chip plate consumables for PhysioMimix organ-on-a-chip studies.

  • Organ-on-a-chip models

    Single-organ and multi-organ models including liver, lung, and gut/liver systems.

  • Support packages

    Support services for users of PhysioMimix technology.

Turnaround
Within weeks
What to send
Customer supplies required amount of drug(s)

Capabilities

Assays and studies
ADME · Toxicology · In vivo · Antibodies · Small molecules · Rodent models · Fibrosis assays · Steatosis assays · Inflammation assays · Hepatotoxicity assays · Drug metabolism assays · Metabolite identification
4 morePermeability assays · Bioavailability prediction · CYP induction/inhibition · Drug-drug interaction studies
Therapeutic areas
Metabolic dysfunction-associated steatohepatitis · Drug-induced liver injury · Immune-mediated liver injury · Hepatitis B · Pulmonary infection · Drug absorption · Drug metabolism · Drug bioavailability

Instruments and platforms

  • PhysioMimix Core
  • PhysioMimix multi-chip plates

Modalities and species

Modalities
Small molecule · Antibody · Oligonucleotide · Cell therapy · Gene editing
Species and models
Human · Rat · Dog · Liver-on-a-chip model · Lung-on-a-chip model · Gut/liver-on-a-chip model

Company

Founded
2018
Team
73% of employees are scientists or engineers
Quality
FDA ISTAND program (PhysioMimix technology accepted into FDA ISTAND) · FDA-recognized (PhysioMimix robustness, reliability, and enhanced performance over traditional approaches)

Locations

Address
332 Cambridge Science Park, Milton Road Cambridge, CB4 0WN UK:
Sites
Cambridge, UK
Serves
UK, US, China, Australia, Japan, Korea

Similar labs

Work here? Claim this listing